GTR Home > Tests > Search results - C1832425[DISCUI]

Apply filters

Showing tests for all 1707 conditions

Compare labs

Your search term can be found in tests with a total of 1707 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1832425[DISCUI]

C Clinical test, R Research test

Showing 1 to 18 of 18 tests for 1707 conditions in 13 labs

CDeafness, autosomal dominant type 9

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CCOCH. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CEYA4. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNonsyndromic Hearing Loss and Deafness NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (53)
Total targets (50)

COtoGenome Test for Hearing Loss (87 Genes)

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (111)
Total targets (86)

COtoSCOPE

Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (98)
Total targets (92)

CAutosomal dominant nonsyndromic sensorineural deafness type DFNA

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNon syndromic deafness AD, AR and XL (NGS panel for 79 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Total conditions (74)
Total targets (79)

CNon syndromic deafness AD (NGS panel for 33 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Total conditions (30)
Total targets (32)

CDeafness, autosomal dominant 9 (sequence analysis of COCH gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCOCH

Test targets
Methods
  • S Mutation scanning of the entire coding region

CCOCH

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSensorineural Hearing Loss

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (81)
Total targets (78)

CHearing Loss: Sequencing Panel

Total conditions (159)
Total targets (92)

CHearing Loss NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (202)
Total targets (103)

CDFNA 9 Nonsyndromic Hearing Loss and Deafness

Lab: Bioscientia GmbH Center for Human Genetics Ingelheim, Rheinland-Pfalz, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 18 of 18 tests for 1707 conditions in 13 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.